Tfg Asset Management Gp LTD Autolus Therapeutics PLC Transaction History
Tfg Asset Management Gp LTD
- $294 Million
- Q2 2024
A detailed history of Tfg Asset Management Gp LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 8,000,000 shares of AUTL stock, worth $28 Million. This represents 9.47% of its overall portfolio holdings.
Number of Shares
8,000,000
Previous 7,525,682
6.3%
Holding current value
$28 Million
Previous $48 Million
42.02%
% of portfolio
9.47%
Previous 16.27%
Shares
20 transactions
Others Institutions Holding AUTL
# of Institutions
115Shares Held
166MCall Options Held
34.2KPut Options Held
19.5K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$74.7 Million86.45% of portfolio
-
Blackstone Inc New York, NY20.5MShares$71.7 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA17.9MShares$62.6 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$53.5 Million1.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$43.2 Million0.59% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $318M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...